​

Funding Round

Series D - NanoCellect Biomedical

Series D - NanoCellect Biomedical

Investment Firm

Overview

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

Announced Date

Aug 13, 2021

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Warburg Pincus

Warburg Pincus

Warburg Pincus is a convertible_note and early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorCasdin Capital
Participant InvestorAnzu Partners
Participant InvestorWarburg Pincus
Participant InvestorFusionX Ventures
Participant InvestorIllumina Ventures

Round Details and Background

NanoCellect Biomedical raised $20000000 on 2021-08-13 in Series D

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 01, 2021
Series C - NanoCellect Biomedical
6-15.0M
Aug 13, 2021
Series D - NanoCellect Biomedical
7-20.0M
Nov 29, 2017
Series B - NanoCellect Biomedical
6-10.0M
Jan 22, 2016
Venture Round - NanoCellect Biomedical
-1.8M

Recent Activity

There is no recent news or activity for this profile.